Grants per year
Personal profile
Research Interests
My primary research interest is the induction of transplant tolerance; this applies to the prevention and treatment of a/cGVHD in hematopoietic stem cell transplantation and prevention and treatment of rejection in solid organ transplantation.
Developing new, non-toxic approaches to the induction of tolerance in the allogeneic transplant setting.
Hematopoietic stem cell transplantation in pediatric patients.
Certifications and Licenses
| Pediatrics | |
| Pediatric Hematology-Oncology |
Training Experience
| 2002 | Residency, Children's Hospital of Orange County |
| 2006 | Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital) |
| 2007 | Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital) |
Education/Academic qualification
MD, Chicago Medical School
… → 1998
Research interests
- Apoptosis
- Immune Regulation
- Stem Cells
- Transplantation
Fingerprint
Dive into the research topics where Jennifer Schneiderman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 2 Finished
-
Extracorporeal Photopheresis (ECP) as a Novel Strategy for Transplant Tolerance Induction
Schneiderman, J. & Levitsky, J.
Northwestern Memorial Hospital
1/1/16 → 12/31/17
Project: Research project
-
Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia
Locatelli, F., Thompson, A. A., Kwiatkowski, J. L., Porter, J. B., Thrasher, A. J., Hongeng, S., Sauer, M. G., Thuret, I., Lal, A., Algeri, M., Schneiderman, J., Olson, T. S., Carpenter, B., Amrolia, P. J., Anurathapan, U., Schambach, A., Chabannon, C., Schmidt, M., Labik, I., Elliot, H., & 4 others, Feb 3 2022, In: New England Journal of Medicine. 386, 5, p. 415-427 13 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis
Liu, H. D., Su, L., Winters, J. L., Thibodeaux, S. R., Park, Y. A., Wu, Y. Y., Schwartz, J., Zubair, A. C., Schneiderman, J., Gupta, G. K., Ramakrishnan, S. & Aqui, N. A., Sep 2022, In: Cytotherapy. 24, 9, p. 916-922 7 p.Research output: Contribution to journal › Article › peer-review
-
Hematopoietic Stem Cell Transplantation in ARPC1B Deficiency
Giardino, S., Volpi, S., Lucioni, F., Caorsi, R., Schneiderman, J., Lang, A., Khojah, A. M., Kuijpers, T., Papadatou, I., Paisiou, A., Alonso, L., Schulz, A., Marcus, N., Gattorno, M. & Faraci, M., 2022, (Accepted/In press) In: Journal of Clinical Immunology.Research output: Contribution to journal › Article › peer-review
-
Lack of defined apheresis collection criteria in publicly available CAR-T cell clinical trial descriptions: Comprehensive review of over 600 studies
the Immune Effector Cell Therapy Subcommittee, Clinical Applications Committee, American Society for Apheresis, Jun 2022, In: Journal of clinical apheresis. 37, 3, p. 223-236 14 p.Research output: Contribution to journal › Article › peer-review
-
Pre-transplant infusion of donor leukocytes treated with extracorporeal photochemotherapy induces immune hypo-responsiveness and long-term allograft survival in murine models
Schneiderman, J., Qiu, L., Yeap, X. Y., Kang, X., Zheng, F., Ye, J., Xie, Y., Wang, J. J., Sambandam, Y., Mathew, J., Li, L., Leventhal, J., Edelson, R. L. & Zhang, Z. J., Dec 2022, In: Scientific reports. 12, 1, 7298.Research output: Contribution to journal › Article › peer-review
Open Access